phase readout
saveNCT06126497: Study Evaluating Safety and Efficacy of Ropanicant in MDD Patients
COMPLETEDupdated 2mo ago
community read0 votes
Sponsor: Suven Life Sciences Limited. Phase: PHASE2. Conditions: Major Depressive Disorder
view source ↗
comments(0)
5-min edit window · permanent after that